Article info
Parallel Session B: Thursday 12 September 2013
Cardiovascular diseases
OP25 Benefits and Risks from Aspirin use in the Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review and Overview of Reviews of Randomised Trial Evidence
Citation
OP25 Benefits and Risks from Aspirin use in the Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review and Overview of Reviews of Randomised Trial Evidence
Publication history
- First published September 10, 2013.
Online issue publication
September 10, 2013
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2013, Published by the bMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions